{Reference Type}: Journal Article
{Title}: Schnitzler Syndrome: Insights into Its Pathogenesis, Clinical Manifestations, and Current Management.
{Author}: Braud A;Lipsker D;
{Journal}: Biomolecules
{Volume}: 14
{Issue}: 6
{Year}: 2024 May 31
{Factor}: 6.064
{DOI}: 10.3390/biom14060646
{Abstract}: Schnitzler syndrome is a rare disorder characterized by a chronic urticarial rash associated with immunoglobulin M (IgM) monoclonal gammopathy. Schnitzler syndrome shares strong clinicopathologic similarities with monogenic IL-1-mediated autoinflammatory disorders and is now considered an acquired adult-onset autoinflammatory disease. The spectacular effect of interleukin-1 inhibitors demonstrates the key role of this cytokine in the pathogenesis of the disease. However, the physiopathology of Schnitzler syndrome remains elusive, and the main question regarding the relationship between autoinflammatory features and monoclonal gammopathy is still unanswered. The purpose of this narrative review is to describe what is currently known about the pathogenesis of this peculiar disease, as well as to address its diagnosis and management.